Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't
Source: Motley Fool
2026-03-26 18:04:22 ET
Morris Shannon, Chief Medical Officer of Erasca (NASDAQ:ERAS) , reported the exercise and immediate sale of 20,000 shares of Common Stock for a transaction value of approximately $301,000, according to a SEC Form 4 filing .
Transaction value based on SEC Form 4 weighted average purchase price ($15.04); post-transaction direct holdings were zero following the transaction.
* 1-year price change calculated using March 26, 2026 as the reference date.
Erasca Inc.
NASDAQ: ERAS
ERAS Trading
6.67% G/L:
$16.15 Last:
1,607,148 Volume:
$15.39 Open:
ERAS Latest News
March 12, 2026 04:01:00 pm
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
ERAS Stock Data
$3,659,231,070
262,117,305
1.32%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
